carteolol has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sasaki, H | 1 |
Naka, K | 1 |
Kishi, Y | 1 |
Ohoshi, T | 1 |
Hagihara, T | 1 |
Matsuo, H | 1 |
Sowa, R | 1 |
Matsumoto, G | 1 |
Sanke, T | 1 |
Nanjo, K | 1 |
Takahashi, H | 1 |
Nakano, K | 1 |
Yasuda, T | 1 |
Komiyama, Y | 1 |
Murakami, T | 1 |
Nishimura, M | 1 |
Nakanishi, T | 1 |
Sakamoto, M | 1 |
Nanbu, A | 1 |
Yoshimura, M | 1 |
Saitoh, Y | 1 |
Tani, T | 1 |
Asahi, Y | 1 |
Man, Z | 1 |
Kawano, K | 1 |
Ikunaga, H | 1 |
3 other studies available for carteolol and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Nicardipine may impair glucose metabolism in hypertensive diabetic patients.
Topics: Adult; Aged; Atenolol; Carteolol; Diabetes Mellitus, Type 2; Diltiazem; Enalapril; Female; Glucose; | 1994 |
Anti-obesity and anti-diabetic effects of carteolol in non-insulin-dependent diabetic mice.
Topics: Adipose Tissue, Brown; Animals; Blood Pressure; Body Weight; Carbohydrate Metabolism; Cardiac Output | 1994 |
Improving effect of carteolol on bodyweight and carbohydrate and lipid metabolic responses in the OLETF rat.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Animals; Blood Glucose; Body Weight; Carteolol; Cholest | 1997 |